WORLDWIDE‑CORRUPTION

Peru · Findings · Debarred / sanctioned abroad × US SEC issuer

BMY · SUB~ · PE · Bristol Myers Squibb Peru S.A & Perufarma S.A

Why it is here

Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'BRISTOL MYERS SQUIBB A ~0.80' «Bristol Myers Squibb Peru S.A & Perufarma S.A» ↔ SEC BMY (CIK 14272, BRISTOL MYERS SQUIBB CO): 1 non-competitive contracts at the buyer «CENTRO NACIONAL DE ABASTECIMIENTO DE RECURSOS ESTRATEGICOS EN SALUD», 1,251,192 PEN (≈ $337,822); method direct (Exoneración); OCID ocds-dgv273-seacev3-44891; ⚑ REPEAT: already sanctioned SEC by FCPA (2015-10-05 Bristol-Myers Squibb).

Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.

Details

Company / subject
BMY · SUB~ · PE · Bristol Myers Squibb Peru S.A & Perufarma S.A
Indicator
Debarred / sanctioned abroad × US SEC issuer
Amount
337,822
Records behind the indicator
1
Found
4 October 2026
Code
W-02379
Reference
ocds-dgv273-seacev3-44891
Reference
2015-10-05

Other records of this company3

  1. 014 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer
  2. 024 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer
  3. 034 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer

JSONFindings · Debarred / sanctioned abroad × US SEC issuer